Top advances of the year: The status of chimeric antigen receptor T cells in neuro-oncology

Published 1 day ago• 1 minute read

No abstract available

chimeric antigen receptor (CAR) T cell; diffuse midline glioma; glioblastoma; immunotherapy.

PubMed Disclaimer

REFERENCES

Sterner RC, Sterner RM. CAR‐T cell therapy: current limitations and potential strategies. Blood Cancer J. 2021;11(4):69. doi:10.1038/s41408‐021‐00459‐7

Loading...

Loading...

Loading...

You may also like...

article preview

Guidance and Discussion on 'Overcoming Conflict at Home'

article preview

Nigerian Minister Bagudu States Economy is 'Back on Track' Despite Challenges

article preview

Kenyan Speaker Wetang'ula Accuses Opposition of Fueling Voter Anger

article preview

Reports of Three Unexplained Deaths of Men in Homa Bay, Kenya

article preview

Nigeria Commemorates June 12 Democracy Day with Holiday and Events

article preview

Political Figures Visit President Tinubu in Lagos During Sallah

article preview

Sokoto Governor Provides N450,000 Sallah Gift to Each Pilgrim

article preview

NDLEA Seizes Drugs, Including Cannabis Disguised as Green Tea, at Lagos Airport